- Home
- SOPH
SOPH
SOPHiA GENETICS SA
as 12-20-2024 4:00pm EST
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
| Founded: | 2011 | Country: | Switzerland |
| Employees: | N/A | City: | N/A |
| Market Cap: | 226.6M | IPO Year: | 2021 |
| Target Price: | $7.00 | AVG Volume (30 days): | 21.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.09 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.70 - $7.37 | Next Earning Date: | 11-05-2024 |
| Revenue: | $64,488,000 | Revenue Growth: | 9.85% |
| Revenue Growth (this year): | 7.2% | Revenue Growth (next year): | 15.71% |
Latest SOPHiA GENETICS SA News
SOPH Breaking Stock News: Dive into SOPH Ticker-Specific Updates for Smart Investing
Simply Wall St.
20 days ago
US Penny Stocks To Watch In December 2024
PR Newswire
a month ago
SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024
Simply Wall St.
a month ago
Earnings Release: Here's Why Analysts Cut Their SOPHiA GENETICS SA (NASDAQ:SOPH) Price Target To US$6.00
TipRanks
2 months ago
SOPHiA GENETICS Faces Financial Challenges Amid Losses
Simply Wall St.
2 months ago
SOPHiA GENETICS Third Quarter 2024 Earnings: Misses Expectations
GuruFocus.com
2 months ago
Sophia Genetics SA (SOPH) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...
Thomson Reuters StreetEvents
2 months ago
Q3 2024 Sophia Genetics SA Earnings Call
MT Newswires
2 months ago
Sophia Genetics Hires George Cardoza as CFO
Compare SOPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SOPH SOPHiA GENETICS SA - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.